Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy
Science Advances · 23.05.2025 · 11 (21)
DOI: 10.1126/sciadv.adv2930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 23.05.2025. Verfasst von Wenxi Xia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT 84112, USA. Hauptthemen laut MEDLINE: Rhabdoid Tumor, Mitochondria, Radiotherapy, Image-Guided. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Tumor hypoxia leads to radioresistance and markedly worse clinical outcomes for pediatric malignant rhabdoid tumors (MRTs). Our transcriptomics and bioenergetic profiling data reveal that mitochondrial oxidative phosphorylation is a metabolic vulnerability of MRT and can be exploited to overcome consumptive hypoxia by repurposing an FDA-approved antimalarial drug, atovaquone (AVO). We then establish the utility of oxygen-enhanced-multispectral optoacoustic tomography, a label-free, ionizing radiation-free imaging modality, to visualize and quantify spatiotemporal changes in tumor hypoxia in response to AVO. We show a potent but transient increase in tumor oxygenation upon AVO treatment that results in complete elimination of tumors in all tested mice when combined with 10-gray radiotherapy, a dose several times lower than the current clinic standard. Last, we use translational mathematical modeling for systematic evaluation of dosing regimens, administration timing, and therapeutic synergy in a virtual patient cohort. Together, our work establishes a framework for safe and pediatric patient-friendly image-guided metabolic radiosensitization of rhabdoid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT 84112, USA.
- Mathematics in Medicine Program, Department of Medicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
- Department of Chemical, Materials and Industrial Production Engineering, University of Naples Federico II, Naples, Italy.
- Physiology, Biophysics, and Systems Biology Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10065, USA.
- Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84132, USA.
- Department of Medical Physics, University of Wisconsin-Madison, Madison, WI 53705, USA.
ORCID-Profile: Wenxi Xia, Esther Need, Jiemin Huang, Joseph Cave, David L Gillespie, Mark D Pagel, Prashant Dogra, Sixiang Shi, Shreya Goel
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Xia, W., Need, E., Schiavone, C., Singh, N., Huang, J., Goff, M., Cave, J., Gillespie, D. L., Jensen, R. L., Pagel, M. D., Dogra, P., Shi, S., & Goel, S. (2025). Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy. Science Advances, 11(21). https://doi.org/10.1126/sciadv.adv2930
Vancouver
Xia W, Need E, Schiavone C, Singh N, Huang J, Goff M, et al. Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy. Science Advances. 2025;11(21). doi:10.1126/sciadv.adv2930
BibTeX
@article{Xia2025,
author = {Xia, Wenxi and Need, Esther and Schiavone, Carmine and Singh, Neetu and Huang, Jiemin and Goff, Matthew and Cave, Joseph and Gillespie, David L and Jensen, Randy L and Pagel, Mark D and Dogra, Prashant and Shi, Sixiang and Goel, Shreya},
title = {Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {21},
doi = {10.1126/sciadv.adv2930}
}
EUVIMED